Biogen Idec GmbH
-
Pharmaceutical Sales 2008
-
Worldwide: 4.097 billion US $
-
Product Range
-
Pharmaceuticals for treating Multiple Sclerosis and Psoriasis
-
Key Research Areas
-
Immune modulation, Oncology, Neuro degeneration
-
R&D Expenditure 2008
-
Worldwide: 1.072 billion US $
-
Employees in the Pharmaceuticals Division 2008
-
Worldwide: ca. 4,700
In Germany: 160
(All data based on corporate information, as of: 05/2009)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.